EUVIMEDEUVIMED entdecken
Crossref

Protective effect of histatin 5 and amphotericin B conjugated nanostructures in C. albicans challenged Swiss albino mice

Saraswathi Nagaraj, Shoba Narayan

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-03997-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Saraswathi Nagaraj und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamil…. Hauptthemen laut MEDLINE: Amphotericin B, Candida albicans, Antifungal Agents, Histatins. Die Arbeit nennt 67 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the development of silica-gold nanostructures conjugated with histatin 5 (H5) and amphotericin B (AmpB) for the management of Candida albicans-induced candidiasis. H5 and AmpB were covalently attached to the silica-gold nanostructures (ASinp-GN) using EDC-NHS chemistry, with fluorescent FITC labeling employed in a parallel experiment to study nanostructure localization. Characterization techniques, including UV-Vis spectroscopy, dynamic light scattering, zeta potential analysis, fluorescence spectroscopy, differential scanning calorimetry, thermogravimetric analysis, high-resolution transmission electron microscopy, atomic force microscopy, and drug release studies, confirmed the successful conjugation and stability of the nanostructures. Biological evaluations using C. albicans demonstrated a minimum inhibitory concentration (MIC50) of 5.42 μM for AmpB in the nanostructures, along with enhanced localization as observed via fluorescence microscopy. The nanostructures effectively inhibited biofilm formation and showed high biocompatibility in hemolysis and MTT assays. In vivo studies using a disseminated candidiasis model in Swiss albino mice revealed significant therapeutic efficacy, evidenced by reduced C. albicans burden, decreased AmpB toxicity, improved heart function, and preserved tissue integrity. These results highlight the role of H5 conjugation in targeted drug delivery, enhancing the therapeutic potential of AmpB while minimizing adverse effects, making it a promising approach for candidiasis management. However, a detailed pharmacokinetic investigation on the use of these nanostructures is warranted before taking this to the clinical side.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphotericin BCandida albicansAntifungal AgentsHistatinsCandidiasisNanostructuresAnimalsMiceMicrobial Sensitivity TestsGoldBiofilmsSilicon DioxideMaleDrug LiberationFemale

Stichwörter der Autor:innen

AntifungalsHistatin 5In vivo studiesNanostructuresSwiss albino mice

Substanzen

Amphotericin BAntifungal AgentsHistatinsGoldSilicon Dioxide

Autor:innen und Institutionen

  • Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamil Nadu, India.
  • Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamil Nadu, India. shobulu@gmail.com.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Nagaraj, S., & Narayan, S. (2025). Protective effect of histatin 5 and amphotericin B conjugated nanostructures in C. albicans challenged Swiss albino mice. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-03997-0

Vancouver

Nagaraj S, Narayan S. Protective effect of histatin 5 and amphotericin B conjugated nanostructures in C. albicans challenged Swiss albino mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-03997-0

BibTeX
@article{Nagaraj2025,
  author = {Nagaraj, Saraswathi and Narayan, Shoba},
  title = {Protective effect of histatin 5 and amphotericin B conjugated nanostructures in C. albicans challenged Swiss albino mice},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-03997-0}
}
Kostenlos starten →